Diabetes cure? Adult stem cells allow Insulin cells to regenerate

Diabetes cure? Adult stem cells allow Insulin cells to regenerate
Posted on November 16 2008

Read 1,620 times.

The headlines proclaim “stem Cell success in Type I Diabetes.”
The headlines are misleading in several ways.

A better headline is in USAToday: “Stem cells “reset” to fight diabetes“, which is more correct but still unclear and misleading.
The disease being discussed is Type I Diabetes, that usually strikes young people. This is not the Type II diabetes that fat people and older people get, where you stil have insulin produced but not enough insulin. This is the one where you don’t have any insulin at all, and without shots will die within a week.

It is believed that Type I diabetes is an “autoimmune” disease. After a viral infection, for some reason the antibodies against the virus instead attack the Beta cells of the Pancreas, the cells that produce insulin.

So you see a child after a virus, and he’s sick and then starts feeling lousy. It’s not common, and easy to miss until the child ends up in the Emergency room dehydrated or in a coma.

But then, sometimes there is a “honeymoon” period when the Diabetes goes away, before it returns. It is thought that the virus hits the beta cells and destroys them, but then the beta cells regenerate or recover for awhile, until finally destroyed by the immune reaction.

That is why doctors are experimenting to see if treating newly diagnosed cases with Prednisone or other medicines that lower the immune response.

In this “stem cell study”, what was done was a variation on bone marrow transplant, where instead of using bone marrow, they used stem cells from the patient’s bone marrow to regenerate the immune system. So what they did was destroy the older cells that had been producing antibody that destroyed the Beta cells that produced insulin. To do this, they essentially destroyed the entire bone marrow.

But then they did a bone marrow transplant–using immature cells from the person’s own bone marrow. These immature cells would transform themselves into all the usual cells, but with the advantage that they were starting over in making an immune response, so they don’t produce antibodies to destroy the beta cells.

I think of this as gardening: You have bad plants full of rust or aphids (cells producing antibodies against the body), so you burn off the field and replace it with new seeds. (replacing the mature marrow with baby cells, i.e. stem cells).
Similar studies have been done using donor bone marrow, but using a donor increases the chance of rejection. This uses one’s own cells, and essentially “regrows” the marrow with immature cells that aren’t “primed” to make the bad antibody.
The procedure is exciting, since it could be used in other diseases where the body’s immune system destroys good tissue, such as Lupus or Multiple Sclerosis.

The bad news is that if you don’t have beta cells still alive, the treatment won’t work.

And that comes to the final confusion: The stem cells were adult stem cells, which are plentiful in the bone marrow. But with all the bills trying to reverse federal funding for Embryonic stem cell research, many people are not aware that adult stem cells are not only easier to obtain and a better genetic match, but have resulted in many types of treatment.

Which is why the LATimes, who backed spending millions to fund embryonic research, reminds readers that even though this used adult stem cells, we still need embryonic stem cells to make beta cells to transplant…

Well, maybe. Or maybe not. THIS ARTICLE discusses the theoretical pros and cons of adult vs embryonic stem cells for Diabetes. Both can produce beta cells, but the research is still preliminary, and years until treatment is started.

Embryonic stem cells potentially can become anything, but have the problem of overgrowing, not as good a genetic match, so people would have to stay on drugs to keep their immune system from rejecting the new cells. They are also hard to obtain, and very expensive. (few “left over” embryos are rarely donated by parents, who tend to view such embryos as potential life, and most embryos sitting around in freezers are “old” since newer fertility methods don’t “waste” as many embryos. That’s why most experiments are done with eggs and sperm donated from college students who are paid to take medicine to stimulate egg production).
Adult stem cells don’t overgrow, and scientists have already produced beta cells from bone marrow and liver. And you don’t have the problem of genetically different cells.
But unless you get rid of the destructive antibody that caused type I diabetes, mere transplants of insulin producing beta won’t help in type I Diabetes. You will need transplants plus anti immune drugs, or tranplants plus this bone marrow replacement with stem cells.

On the other hand, Type I Diabetes is so bad, it’s worth the effort.

Stem cells could provide a solution to diabetes

Stem cells could provide a solution to diabetes
Posted on October 22nd, 2006
by Ishan Wadi
Read 716 times.

News published in the Nature Biotechnology journal, suggests that researchers are close to developing an effective treatment for diabetes, using stem cells. Researchers at Novocell, a company in the field of stem-cell engineering, have announced that stem cells from embryos could be used to repair insulin-producing tissues in the body affected by diabetes, as they have the ability to divide and differentiate in to many other types of cells.

Diabetes is a chronic, metabolic disease, which causes numerous complications including cardiovascular illnesses and it can turn fatal if left untreated. Nearly two million people suffer from diabetes in United States and more than 200,000 of them die each year from the complications triggered by this disease. Diabetes is a global health issue and scientists around the world are working to find an effective solution or treatment to this disease. However, diabetes can be managed easily through lifestyle modifications such as achieving or maintaining proper weight, diet, exercise and foot care.

Emmanuel Baetge, the chief scientific officer at Novocell, said that the efficient production of human embryonic cells, which can develop in to insulin producing endocrine cells through a process that is similar to the development of human pancreatic cells, is a remarkable achievement in the treatment of diabetes, as such stem cells can serve as a renewable source of cells for diabetes therapy.

Recently Created Blog

Wud be back with all the posts soon